Week in Review: China National Biotec Plans $1.6 Billion Hong Kong IPO
01:00 EDT 9 Sep 2012 | ChinaBio Today
China National Biotec announced that its upcoming Hong Kong IPO, which now awaits only CSRC approval, will raise as much as $1.6 billion; Triplex International Biosciences, a Xiamen diagnostics company, received a $50 million capital infusion from..
Original Article: Week in Review: China National Biotec Plans $1.6 Billion Hong Kong IPO
More From BioPortfolio on "Week in Review: China National Biotec Plans $1.6 Billion Hong Kong IPO"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
